Warsaw, Indiana-based ZB’s agreement with Surgical Planning Associates around the commercialization of its HipInsight.
HipInsight is the first FDA-cleared, mixed-reality navigation system for total hip replacement. It is customized for Zimmer Biomet’s hip implant portfolio, according to a news release. It allows surgeons to use Microsoft HoloLens 2 glasses to visualize a hologram of the patient’s pelvic anatomy during surgery.
Zimmer Biomet said that HipInsight expands the capabilities of its ZBEdge suite of integrated smart, digital and robotic technologies. The company added HipInsight to its OptiVu mixed reality portfolio of applications.
“The addition of HipInsight to our mixed reality portfolio advances our commitment to transform the surgical experience with the latest innovative technologies to help surgeons improve accuracy, strive for better outcomes and optimize efficiency during total hip arthroplasty,” said Dr. Nitin Goyal, chief science, technology and innovation officer at Zimmer Biomet. “This collaboration enables us to offer surgeons a sophisticated and proven mixed reality-based visualization tool customized for exclusive use with our hip implant portfolio.”
HipInsight offers a detailed, CT-based 3D surgical plan with information for accurate and efficient implant positioning. It provides planned component size, pelvic tilt, leg length and offset change.
During surgery, the use of mixed-reality glasses and a smart registration tool overlays holograms in real-time. This gives the surgeon a direct view of the surgical plan over the patient anatomy.
“We’re proud to partner with Zimmer Biomet, a leader in joint arthroplasty, to co-market HipInsight for their portfolio of hip implant systems,” said Dr. Stephen B. Murphy, founder of Surgical Planning Associates. “Unlike traditional intraoperative surgical navigation systems that provide information on flat screens outside the surgeon’s view, HipInsight leverages Microsoft HoloLens 2 mixed reality glasses in a truly innovative fashion to display images and information within the surgeons’ field of view to support accurate implant positioning. This collaboration is the next step in our journey to make mixed-reality-based surgical guidance the standard of care in orthopedics.”